Intervention/Treatment
ApprovedUNKNOWN 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Endogenous Cushing Syndrome
Conditions
Endogenous Cushing Syndrome
Trial Timeline
Oct 24, 2023 → Nov 24, 2025
NCT ID
NCT06131580About Intervention/Treatment
Intervention/Treatment is a approved stage product being developed by Recordati for Endogenous Cushing Syndrome. The current trial status is unknown. This product is registered under clinical trial identifier NCT06131580. Target conditions include Endogenous Cushing Syndrome.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06131580 | Approved | UNKNOWN |
Competing Products
2 competing products in Endogenous Cushing Syndrome
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Osilodrostat | Recordati | Pre-clinical | 20 |
| Osilodrostat | Recordati | Pre-clinical | 20 |